although
air
sampl
extens
use
research
studi
specif
clinic
situat
eg
assess
risk
aerosolgener
still
routin
use
hospit
infect
control
situat
though
applic
explor
current
team
sever
possibl
reason
despit
wide
choic
air
sampler
either
develop
inhous
commerci
avail
infect
control
team
may
access
one
andor
familiar
use
outsid
specif
research
studi
context
air
sampler
costli
ii
use
air
sampler
requir
laboratori
support
use
ie
abl
process
air
sampl
routin
manner
may
consist
air
sampl
collect
fluid
viru
transport
media
vtm
obtain
liquid
imping
air
sampler
gel
disc
solid
captur
media
dissolv
vtm
test
would
usual
perform
use
molecular
method
mostli
polymeras
chain
reaction
pcr
test
addit
viral
cultur
confirm
viru
viabil
air
sampl
howev
hospit
diagnost
laboratori
autom
perform
convent
repetit
assay
human
patient
tissu
fluid
train
manpow
run
complex
research
assay
especi
use
test
air
sampl
sensit
convent
diagnost
assay
iii
perhap
importantli
interpret
result
problemat
consensu
guidelin
level
airborn
pathogen
constitut
definit
infect
control
risk
patient
staff
visitor
threshold
like
differ
differ
patient
popul
pathogen
eg
influenza
bone
marrow
transplant
versu
respiratori
syncyti
viru
gener
paediatr
ward
without
definit
pathogen
patientspecif
risk
threshold
guidanc
difficult
hospit
infect
control
team
appli
find
support
routin
air
sampl
part
daili
practic
relat
practic
issu
defin
clinic
relev
threshold
limit
detect
lod
molecular
assay
use
test
air
sampl
follow
exampl
illustr
issu
note
figur
discuss
illustr
purpos
method
equip
base
author
current
experi
typic
air
sampler
switch
sampl
specif
airflow
rate
eg
lmin
skc
biosampl
cat
seri
skc
ltd
blandford
forum
uk
specif
period
time
eg
h
time
period
may
pure
arbitrari
often
correl
actual
durat
interact
staff
patient
visitor
air
sampl
draw
total
air
volum
l
min
l
environ
skc
biosampl
amount
air
suck
flask
contain
swirl
volum
ml
vtm
eg
virocult
medic
wire
equip
corsham
uk
captur
virus
present
air
aliquot
ml
vtm
extract
test
use
pcr
detect
viru
present
pathogen
interest
respiratori
syncyti
viru
rsv
exampl
assay
detect
minimum
dna
copiesml
vtm
report
lod
ausdiagnost
respiratori
viru
pcr
assay
interpret
riskassess
result
air
sampl
air
sampl
gener
practition
famili
doctor
clinic
hospit
paediatr
ward
autumn
winter
may
necessarili
unusu
detect
respiratori
virus
rsv
continu
illustr
exampl
backcalcul
airborn
viral
load
specif
pcr
reaction
volum
let
us
assum
rsv
rna
copi
detect
air
sampl
collect
skc
biosampl
ie
repres
copi
rsv
rna
ml
vtm
total
volum
skc
biosampl
result
sampl
air
equat
air
rsv
rna
level
rsv
rna
air
pose
risk
patient
staff
visitor
vicin
gener
speak
level
airborn
viru
detect
becom
concern
interven
answer
clearli
contextdepend
depend
immun
statu
expos
turn
partial
determin
pathogen
specif
infecti
dose
ie
amount
organ
requir
caus
infect
potenti
diseas
also
vari
individu
depend
past
exposur
current
level
specif
immun
specif
pathogen
includ
histori
vaccin
avail
anoth
layer
complex
pose
use
pcr
test
air
sampl
pcr
distinguish
live
inactiv
viru
individu
infecti
dose
estim
specif
pathogen
specif
expos
popul
need
take
account
final
even
knew
actual
know
exactli
much
air
volum
need
inhal
specif
individu
achiev
infecti
dose
make
calcul
simpl
would
assum
uniform
distribut
airborn
pathogen
within
air
volum
calcul
volum
air
requir
inhal
achiev
infecti
dose
furthermor
unclear
much
inhal
air
either
reexhal
much
contact
airborn
pathogen
correspond
host
cell
receptor
ie
virus
may
distribut
differ
within
respiratori
tract
differ
individu
work
exampl
infecti
dose
rsv
rsv
rna
air
specif
expos
popul
know
previou
experi
detect
rsv
rna
ie
rsv
rna
detect
rsv
viabl
unlik
secondari
case
rsv
occur
airborn
infecti
dose
rsv
reach
follow
case
report
describ
child
chronic
respiratori
adenoviru
adv
infect
highlight
sever
point
rais
ultim
case
result
togeth
understand
close
natur
tracheostomi
system
help
give
confid
staff
manag
patient
expos
clinic
signific
level
adenoviru
air
taken
togeth
find
allow
staff
remov
face
mask
whilst
maintain
routin
contact
transmiss
precaut
enhanc
social
interact
develop
young
patient
tetrapleg
bedbound
young
child
underli
congenit
immunodefici
longterm
ventil
support
via
tracheostomi
becam
chronic
infect
season
respiratori
adenoviru
adv
serotyp
regular
nasopharyng
aspir
npa
show
adv
load
vari
copiesml
million
copiesml
use
quantit
adv
dna
pcr
assay
fourmonth
period
due
high
level
respiratori
adv
potenti
shed
environ
ie
air
onto
surfac
patient
respiratori
tract
hospit
infect
prevent
control
ipc
team
requir
healthcar
staff
wear
person
protect
equip
ppe
manag
patient
consist
don
surgic
mask
face
visor
glove
gown
time
enter
room
whether
physiotherapi
educ
play
period
well
daili
mainten
tracheostomi
paediatr
team
therefor
concern
whether
would
affect
child
psychosoci
develop
staff
eye
facial
express
visibl
child
time
visit
nearpati
air
sampl
initi
assess
actual
exposur
staff
clinic
signific
airborn
level
adv
potenti
produc
patient
eg
via
air
leakag
around
tracheostomi
cuff
determin
whether
high
level
ppe
necessari
skc
button
sampler
gel
filter
power
airchek
pump
calibr
rotamet
suppli
skc
ltd
blandford
forum
uk
use
air
sampl
sampler
use
one
three
way
worn
wardbas
staff
nurs
physiotherapist
educ
play
assist
held
approxim
away
patient
nose
mouth
care
mount
left
stand
overnight
fix
locat
near
patient
sampl
ambient
air
vicin
air
drawn
dissolv
gel
filter
airflow
rate
lmin
pump
calibr
lmin
rotamet
prior
sampl
session
figur
local
room
temperatur
rel
humid
also
measur
start
air
sampl
session
thermopro
itron
shenzhen
guangdong
china
end
sampl
period
gel
filter
care
extract
filter
dissolv
ml
viru
transport
medium
vtm
extract
qiasymphoni
dsp
viruspathogen
kit
qiagen
manchest
uk
run
ausdiagnost
respiratori
virus
cat
ausdiagnost
uk
ltd
chesham
uk
assay
commerci
assay
claim
lower
limit
detect
adv
dna
copiesml
assay
also
use
weekli
test
npa
endotrach
tube
aspir
eta
patient
monitor
progress
chronic
adv
infect
posit
adv
npa
sampl
sent
commerci
laboratori
adv
type
quantif
micropatholog
ltd
coventri
uk
variou
posit
commonli
frequent
staff
routin
care
duti
around
patient
sampl
vari
durat
multipl
time
week
check
presenc
airborn
adv
figur
air
sampl
session
coordin
coincid
day
routin
npa
taken
patient
monitor
adv
level
addit
npa
eta
also
routin
taken
respiratori
viru
pcr
test
check
presenc
adv
lower
respiratori
tract
lrt
air
sampl
session
button
sampler
accompani
tube
thoroughli
wash
warm
soapi
water
rins
airdri
physic
remov
respiratori
viru
nucleic
acid
might
present
insid
surfac
dri
run
use
gel
filter
dissolv
vtm
fail
detect
adv
dna
vtm
also
use
ward
daili
routin
clinic
sampl
neg
extract
pcr
control
normal
diagnost
test
potenti
viral
contamin
monitor
daili
basi
discuss
local
institut
review
board
irb
agre
air
sampl
constitut
environment
sampl
therefor
requir
formal
ethic
approv
total
nine
air
sampl
taken
period
one
month
result
summaris
tabl
figur
seen
even
three
month
prior
air
sampl
studi
period
level
adv
dna
routin
npa
sampl
vari
dramat
rang
million
ie
adv
dna
copiesml
air
sampl
period
variat
limit
million
adv
dna
copiesml
larg
variat
lack
viral
clearanc
like
due
establish
degre
adv
latenc
adenoid
ongo
reactiv
child
underli
primari
congenit
immunodefici
despit
vari
occasion
high
level
adv
dna
level
correspond
npa
sampl
adv
dna
detect
air
sampl
addit
none
eta
sampl
posit
adv
dna
well
neg
control
describ
method
section
control
experi
involv
spike
gel
filter
prior
extract
pcr
patient
posit
adv
npa
sampl
show
inhibit
minim
ct
less
impact
dilut
factor
due
gel
filter
dissolv
ml
vtm
compar
neat
npa
pcr
signal
indic
studi
period
despit
high
level
adv
present
patient
nasal
oropharyng
caviti
littl
viru
releas
air
around
patient
breath
zone
whilst
tracheostomi
situ
studi
sever
limit
also
rais
interest
question
skc
button
sampler
person
portabl
low
volum
sampler
durat
sampl
worn
ward
staff
typic
rel
short
usual
around
min
match
actual
period
interact
patient
time
sampler
would
sampl
lmin
l
air
slightli
less
compar
amount
air
might
inhal
one
ward
nurs
work
vicin
patient
estim
base
tidal
volum
l
respiratori
rate
breath
per
minut
bpm
give
total
inhal
volum
approxim
l
min
depend
activ
level
known
air
sampl
low
pathogen
genom
concentr
gener
problem
analys
air
sampl
metagenom
studi
thu
use
routin
clinic
diagnost
assay
test
air
sampl
may
deem
insuffici
sensit
purpos
assay
inde
optimis
test
clinic
sampl
nasalthroat
swab
npa
eta
bronchoalveolar
lavag
bal
pathogen
concentr
gener
higher
one
futur
option
increas
sensit
assay
air
sampl
would
increas
volum
vtm
sampl
contain
dissolv
gel
filter
input
extract
step
howev
studi
deliber
intend
test
sensit
standard
diagnost
respiratori
pcr
assay
protocol
detect
airborn
viru
pose
question
level
detect
constitut
clinic
risk
detect
level
airborn
pathogen
suffici
caus
infect
nearbi
suscept
host
would
sensit
assay
help
detect
airborn
level
pathogen
threshold
lower
level
airborn
pathogen
pose
clinic
risk
use
use
assay
detect
low
level
airborn
pathogen
intervent
result
use
desensitis
assay
area
diagnost
virolog
well
accept
eg
cmv
viral
load
test
preemptiv
therapi
postbon
marrow
transplant
overli
sensit
cmv
pcr
assay
would
lead
unnecessari
treatment
sever
advers
effect
furthermor
sensit
assay
routin
diagnost
laboratori
expect
capabl
perform
air
sampl
although
sever
studi
perform
nearpati
air
sampl
question
gener
wellinvestig
answer
common
everyday
pathogen
routin
clinic
environ
date
one
estim
aerosolairborn
infecti
dose
influenza
copi
viabl
viru
older
estim
report
bioterror
agent
although
sensit
assay
may
detect
fewer
copi
pathogen
nucleic
acid
air
sampl
actual
clinic
risk
lower
detect
level
viru
pose
still
unclear
patient
fact
eta
ie
deeper
lung
sampl
show
undetect
level
adv
dna
suggest
adv
present
upper
respiratori
tract
urt
probabl
becom
latent
adenoid
theori
adv
region
unlik
expel
airflow
deeper
lung
would
channel
tracheostomi
tracheostomi
cuff
around
tube
hold
place
trachea
also
prevent
escap
air
urt
even
adv
reactiv
shed
adenoid
urt
would
littl
air
enter
urt
lung
aerosolis
exhal
surround
air
thu
theori
adv
would
pure
confin
patient
mouth
saliva
becom
airborn
air
sampl
thu
perform
confirm
theori
ie
clinic
signific
amount
adv
exhal
surround
air
presenc
tracheostomi
howev
import
note
misunderstood
infect
control
team
given
discuss
lack
sensit
convent
diagnost
respiratori
viru
pcr
assay
detect
viral
nucleic
acid
air
sampl
air
sampl
result
alon
may
suffici
allow
staff
remov
respiratori
protect
henc
neg
air
sampl
result
conjunct
close
tracheostomi
system
place
provid
addit
confid
clinic
care
team
clinic
signific
level
adv
aerosolis
environ
might
potenti
lead
nosocomi
staff
infect
direct
inhal
via
selfinocul
aerosolcontamin
fomit
allow
staff
enter
room
without
need
wear
surgic
mask
face
visor
far
result
adenoviru
infect
outbreak
report
amongst
staff
ward
although
infect
prevent
control
guidelin
necessarili
precautionari
gener
univers
avoid
confus
supplement
nearpati
air
sampl
sometim
use
refin
reassur
need
ppe
requir
specif
patient
case
need
aris
